Continuing Education
The Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation. The Drug Information Association designates this educational activity for up to to 6.5 contact hour or .65 CEUs.
Credit Allocation:
Introduction to Drug Development: 1 contact hours or .1 CEUs. UAN: 0286-0000-24-051-H04-P Type of Activity: Application
Discovery and Pre-Clinical Phases: 1 contact hours or .1 CEUs. UAN: 0286-0000-24-052-H04-P Type of Activity: Application
Drug Development Phase 1: 1 contact hours or .1 CEUs. UAN: 0286-0000-24-053-H04-P Type of Activity: Application
Drug Development Phase 2: 1.25 contact hours or .125 CEUs. UAN: 0286-0000-24-054-H04-P Type of Activity: Application
Drug Development Phase 3 and Regulatory Review: 1.5 contact hours or .15 CEUs. UAN: 0286-0000-24-066-H04-P Type of Activity: Application
Drug Development Phase 4 and Lifecycle Management: .75 contact hours or .75 CEUs. UAN: 0286-0000-24-067-H04-P Type of Activity: Knowledge
DIA has been reviewed and approved as a provider of project management training by the Project Management Institute (PMI). This program offers a maximum of 6.5 professional development units (PDUs).
Credit Allocation:
Introduction to Drug Development: 1 PDU PMI #: 21662ER3FL
Discovery and Pre-Clinical Phases: 1 PDU PMI #: 2166BDE0TM
Drug Development Phase 1: 1 PDU PMI #: 2166R9K4KN
Drug Development Phase 2: 1.25 PDU PMI #: 2166PZE66W
Drug Development Phase 3 and Regulatory Review: 1.5 PDU PMI #: 216657ZRUL
Drug Development Phase 4 and Lifecycle Management: .75 PDU PMI #: 2166RZTA0I
The PMI Registered Education Provider logo is a registered mark of the Project Management Institute, Inc.
Drug Information Association (DIA) is accredited by the International Accreditors for Continuing Education and Training (IACET) and offers IACET CEUs for its learning events that comply with the ANSI/IACET Continuing Education and Training Standard. IACET is recognized internationally as a standard development organization and accrediting body that promotes quality of continuing education and training.
As an IACET Accredited Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer .7 CEUs for this program.
Credit Allocation:
Introduction to Drug Development: .1 CEU
Discovery and Pre-Clinical Phases: .1 CEU
Drug Development Phase 1: .1 CEU
Drug Development Phase 2 : .1 CEU
Drug Development Phase 3 and Regulatory Review: .2 CEU
Drug Development Phase 4 and Lifecycle Management: .1 CEU
This event is approved by the Regulatory Affairs Professionals Society for 6 RAC credits.
Statement of Credit:
Statement of Credit and Successful Completion Requirements
To successfully complete this course and receive a statement of credit, you must review at least 90% of the module, achieve a passing score of 80% or better on the post-assessment, and complete the evaluation.
After a module is completed, you will be able to access the module for one year from the date of purchase.
Sign in to My Account to access My Transcripts and request your online credit.